Switching to a newer clot-busting drug improves patient outcomes

AUSTIN, Texas — A new-generation clot-busting drug called tenecteplase is outperforming conventional treatment of ischemic strokes in several key areas, including better health outcomes and lower costs, according to the New study Published today in the American Stroke Association’s Journal brain attack. The study was led by a team of neurologists at Dell Medical College … Read more